scispace - formally typeset
Open AccessJournal ArticleDOI

Dietary lipids, gut microbiota and lipid metabolism

Reads0
Chats0
TLDR
The association between gut microbiota, dietary lipids and lipid metabolism is reviewed and metabolites produced by the gut microbiota such as short-chain fatty acids, secondary bile acids and trimethylamine are reviewed.
Abstract
The gut microbiota is a central regulator of host metabolism. The composition and function of the gut microbiota is dynamic and affected by diet properties such as the amount and composition of lipids. Hence, dietary lipids may influence host physiology through interaction with the gut microbiota. Lipids affect the gut microbiota both as substrates for bacterial metabolic processes, and by inhibiting bacterial growth by toxic influence. The gut microbiota has been shown to affect lipid metabolism and lipid levels in blood and tissues, both in mice and humans. Furthermore, diseases linked to dyslipidemia, such as non-alcoholic liver disease and atherosclerosis, are associated with changes in gut microbiota profile. The influence of the gut microbiota on host lipid metabolism may be mediated through metabolites produced by the gut microbiota such as short-chain fatty acids, secondary bile acids and trimethylamine and by pro-inflammatory bacterially derived factors such as lipopolysaccharide. Here we will review the association between gut microbiota, dietary lipids and lipid metabolism

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Preventive Cardiology AbstractsChronic infections and the risk of carotid atherosclerosis. Prospective results from a large population study

TL;DR: Markers of systemic inflammation, such as soluble adhesion molecules and circulating bacterial endotoxin, and levels of soluble human heat-shock protein 60 and antibodies to mycobacterial heat- shock protein 65 were elevated in subjects with chronic infections and predictive of an increased risk of atherosclerosis.
Journal ArticleDOI

You Are What You Eat-The Relationship between Diet, Microbiota, and Metabolic Disorders-A Review.

TL;DR: How macronutrients (proteins, carbohydrates, fat) and different dietary patterns interact with the composition and activity of GM are described, and how gut bacterial dysbiosis has an influence on metabolic disorders, such as obesity, type 2 diabetes, and hyperlipidemia are described.
Journal ArticleDOI

Regulation of Intestinal Barrier Function by Microbial Metabolites.

TL;DR: A review of recent advances on Gut microbial metabolites in the regulation of intestinal barrier function is presented in this paper, which mainly points to a small group of shared pathways that control gut barrier functions.
Journal ArticleDOI

Role of Oxidative Stress in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Implications for Prevention and Therapy

TL;DR: In this paper, a review highlights the link between disturbed lipid metabolism and oxidative stress in the context of NAFLD and discusses potential therapies based on antioxidant effects and their likely molecular targets.
Journal ArticleDOI

Associations among Dietary Omega-3 Polyunsaturated Fatty Acids, the Gut Microbiota, and Intestinal Immunity.

TL;DR: In this paper, the effects of omega-3 PUFAs on intestinal immunity and inflammation were described, and several pathways by which the microbiota modulates the gut immune system through Omega-3PUFAs were identified.
References
More filters
Journal ArticleDOI

An obesity-associated gut microbiome with increased capacity for energy harvest

TL;DR: It is demonstrated through metagenomic and biochemical analyses that changes in the relative abundance of the Bacteroidetes and Firmicutes affect the metabolic potential of the mouse gut microbiota and indicates that the obese microbiome has an increased capacity to harvest energy from the diet.
Journal ArticleDOI

Metabolic endotoxemia initiates obesity and insulin resistance

TL;DR: It is concluded that the LPS/CD14 system sets the tone of insulin sensitivity and the onset of diabetes and obesity and lowering plasma LPS concentration could be a potent strategy for the control of metabolic diseases.
Journal ArticleDOI

Richness of human gut microbiome correlates with metabolic markers

TL;DR: The authors' classifications based on variation in the gut microbiome identify subsets of individuals in the general white adult population who may be at increased risk of progressing to adiposity-associated co-morbidities.
Journal ArticleDOI

From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites

TL;DR: Data is reviewed supporting the diverse functional roles carried out by a major class of bacterial metabolites, the short-chain fatty acids (SCFAs), which affect various physiological processes and may contribute to health and disease.
Related Papers (5)